InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-27.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Morris Gabriel S, Chief Financial Officer. Director active across 1 company, notably Immix Biopharma, Inc.. Aggregated, 7 reports have been logged. Split: 5 buys · 0 sell. Total volume traded: €29k. Activity tracked since 20 December 2021. The latest transaction was filed on 18 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
2,225 shares@ US$2.279Common StockSEC:0001641172-25-015755:0
Ideal exit: 15 Mar 2026 (T+270)
2,500 shares@ US$2.11923.6% of flowCommon StockSEC:0001493152-24-023288:0
Ideal exit: 4 Mar 2025 (T+270)
3,300 shares@ US$1.80994.0% of flowCommon StockSEC:0001493152-24-022654:0
Ideal exit: 1 Mar 2025 (T+270)
194,218 sharesCommon StockSEC:0001493152-24-020776:0
4,500 shares@ US$2.23156.8% of flowCommon StockSEC:0001493152-24-019368:0
Ideal exit: 8 Feb 2025 (T+270)
5,200 shares@ US$0.943.5% of flowCommon StockSEC:0001493152-22-032555:0
Ideal exit: 11 Aug 2023 (T+270)
74,116 shares@ US$0.850.010% mcap50.0% of flowCommon StockSEC:0001493152-21-032035:0
7 of 7 declarations
About Morris Gabriel S
Gabriel S. Morris is the Chief Financial Officer of Immix Biopharma, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations to ensure compliance and financial health.
